Objective: To evaluate the pharmacokinetic-pharmacodynamic parameters of enrofloxacin and a low dose of amikacin administered via regional IV limb perfusion (RILP) in standing horses.
Animals: 14 adult horses.
Procedures: Standing horses (7 horses/group) received either enrofloxacin (1.